Cleared Traditional

K233637 - Cordis BRITECROSS Support Catheter

K233637 is an FDA 510(k) clearance for Cordis BRITECROSS Support Catheter, manufactured by Cordis US Corp. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 228-day FDA review.

K233637 · Cordis US Corp · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2024
Decision
228d
Days
Class 2
Risk

K233637 is an FDA 510(k) clearance for the Cordis BRITECROSS Support Catheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Cordis US Corp (Miami Lakes, US). The FDA issued a Cleared decision on June 28, 2024 after a review of 228 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Cordis US Corp devices

FDA 510(k) Submission Details - K233637

510(k) Number K233637 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 13, 2023
Decision Date June 28, 2024
Days to Decision 228 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
103d slower than avg
Panel avg: 125d · This submission: 228d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 619
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K233637.
Selectra 3D Lead Delivery System (443624-443629, 451789-451791)
K240787 · Biotronik, Inc. · Sep 2024
ShapeIT (SI014135)
K241611 · Imds Operations B.V. · Sep 2024
TriClip Steerable Guide Catheter
K241538 · Abbott Medical · Aug 2024
ASAHI Veloute
K241158 · Asahi Intecc Co., Ltd. · Jun 2024
React 71 Catheter
K241177 · Micro Therapeutics Lnc. D/B/A Ev3 Neurovascular · May 2024
APRO 55 Catheter
K234115 · Alembic, LLC · Mar 2024